Bersani, Francesca
Picca, Francesca
Morena, Deborah
Righi, Luisella
Napoli, Francesca
Russo, Mariangela
Oddo, Daniele
Rospo, Giuseppe
Negrino, Carola
Castella, Barbara
Volante, Marco
Listì, Angela
Zambelli, Vanessa
Benso, Federica
Tabbò, Fabrizio
Bironzo, Paolo
Monteleone, Emanuele
Poli, Valeria
Pietrantonio, Filippo
Di Nicolantonio, Federica
Bardelli, Alberto
Ponzetto, Carola
Novello, Silvia
Scagliotti, Giorgio V.
Taulli, Riccardo
Funding for this research was provided by:
Associazione Italiana per la Ricerca sul Cancro (Start-Up Grant-15405, IG-25978)
Ministero dell'Università e della Ricerca (RILO)
Compagnia di San Paolo (Excellent Young PI)
Università degli Studi di Torino
Article History
Received: 3 January 2023
Accepted: 27 April 2023
First Online: 12 May 2023
Change Date: 2 October 2023
Change Type: Update
Change Details: Funding note has been updated.
Declarations
:
: All human tissues and clinical information were collected with the approval of the Ethics Committees of San Luigi Gonzaga Hospital, Orbassano, Italy and AOU Città della Salute e della Scienza di Torino Hospital (#73/2018) and in accordance with a Fondazione IRCCS Istituto Nazionale dei Tumori Institutional Review Board-approved protocol. The Blood Bank of AOU Città della Salute e della Scienza, Torino, Italy, provided healthy donors’ peripheral blood (#DS 1033/2016). The study was conducted according to the guidelines of the Declaration of Helsinki. Written informed consent was obtained from each patient. All samples were received anonymously.
: Not applicable.
: S.N. has received personal fees from AbbVie, Boehringer Ingelheim, BMS, Celgene, Eli Lilly, MSD, Takeda, Roche, and Pfizer outside the submitted work. G.V.S. has received personal fees from Eli Lilly, AstraZeneca, Roche, Pfizer, and MSD outside the submitted work.All other authors declare that they have no competing interests.